about
The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerBRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies.In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein.The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fine tuning chemotherapy to match BRCA1 status
@ast
Fine tuning chemotherapy to match BRCA1 status
@en
Fine tuning chemotherapy to match BRCA1 status
@nl
type
label
Fine tuning chemotherapy to match BRCA1 status
@ast
Fine tuning chemotherapy to match BRCA1 status
@en
Fine tuning chemotherapy to match BRCA1 status
@nl
prefLabel
Fine tuning chemotherapy to match BRCA1 status
@ast
Fine tuning chemotherapy to match BRCA1 status
@en
Fine tuning chemotherapy to match BRCA1 status
@nl
P2860
P1476
Fine tuning chemotherapy to match BRCA1 status
@en
P2093
Alvaro N.A. Monteiro
Melissa Price
P2860
P304
P356
10.1016/J.BCP.2010.05.015
P407
P577
2010-09-01T00:00:00Z